A Clinical Trial of CEA Targeting CAR-T for CEA Positive Advanced Lung Cancer

Clinical trial NCT06768151 · RECRUITING

Trial details

NCT number: NCT06768151
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Lung Cancer

Start date: 2024-12-12
Primary completion: 2026-12-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.